期刊
JOURNAL OF RHEUMATOLOGY
卷 46, 期 8, 页码 1021-1027出版社
J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.181096
关键词
OMERACT; THEORETICAL FRAMEWORK; PATIENT OUTCOME; HEALTH STATUS INDICATOR; MEASUREMENT MODEL
类别
资金
- NIHR Leeds Biomedical Research Centre
- VA Medical Center at Birmingham, Alabama, USA
- Pfizer Australia
- AbbVie Australia
- Eli Lilly Australia
- Janssen Australia
Objective. The Outcome Measures in Rheumatology (OMERACT) Filter 2.0 framework was developed in 2014 to aid core outcome set development by describing the full universe of measurable aspects of health conditions from which core domains can be selected. This paper provides elaborations and updated concepts (OMERACT Filter 2.1). Methods. At OMERACT 2018, we discussed challenges in the framework application caused by unclear or ambiguous wording and terms and incompletely developed concepts. Results. The updated OMERACT Filter 2.1 framework makes benefits and harms explicit, clarifies concepts, and improves naming of various terms. Conclusion. We expect that the Filter 2.1 framework will improve the process of core set development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据